Funding News: 17 July 2009
July 17, 2009
In This Issue:
-
* GrantsNet sponsorship
New Research Funding Programs
- Department of Defense.
-
DOD Peer Reviewed Cancer Genetic/Environmental Idea Awards
Idea Awards are to promote the exploration of ideas that are still in the early stages of development yet have the potential to yield high-impact results and open new avenues of investigation in genetic cancer research and its relation to exposure to the various environments that are unique to a military lifestyle. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements. No other topic areas will be allowed. Preliminary data are not required. However, research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. Focus areas are described in the program announcement on pages 2 to 3. Funding: The maximum period of performance is 3 years. The maximum allowable direct cost amount for the entire period of performance is $375,000. In addition to direct costs, indirect costs may be proposed in accordance with the institution's negotiated rate agreement. Deadlines: Preapplication (preproposal) through http://cdmrp.org required and due: 5 August 2009, by 5:00 p.m. Eastern Daylight Time. Preproposals will be screened, and submission of full application is by invitation. Invitations from the Peer Reviewed Cancer Research Program to selected preapplicants: 19 October 2009. Application submitted through www.grants.gov due: 9 December 2009 by 11:59 p.m. Eastern Standard Time. Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DOD Peer Reviewed Cancer Mentor-Predoctoral Fellow Research Awards
Mentor-Predoctoral Fellow Research Awards are designed to promote new ideas that are still in the early stages of development while training outstanding candidates in the topic area of noninvasive cancer ablation treatment research, including selective targeting with nanoparticles. The research should have the potential to yield highly impactful data and new avenues of investigation. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. Mentored training (by an investigator at the level of assistant professor or equivalent) of an outstanding predoctoral fellow is an important aspect of this award, and inclusion of a predoctoral fellow is a requirement. A predoctoral student currently enrolled full-time in an accredited doctoral program (e.g., Ph.D., M.D./Ph.D., D.Sc.) and who has successfully completed comprehensive examinations or otherwise met predissertation requirements by the time of award obligation to the institute or agency. No other topic areas will be allowed. Preliminary data is not required. No clinical trials are permitted. Funding: The maximum period of performance is 3 years. The maximum allowable direct cost amount for the entire period of performance is $475,000 ($375,000 for research plus $100,000 for the predoctoral fellow to cover stipend or salary and tuition). In addition to direct costs, indirect costs may be proposed in accordance with the institution's negotiated rate agreement. Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DOD Peer Reviewed Cancer Melanoma Collaborative Translational Science Awards
The Collaborative Translational Science Awards supports the development of translational research collaborations among two or three independent investigators (known as partners) to address one of the two focus areas in melanoma and other skin cancers in a manner relevant to military service that would be less readily achievable through separate efforts. At least one partner must have experience either in melanoma/other skin cancer research or in melanoma/other skin cancer patient care. It should be clear that all partners have equal intellectual input into the design of the research project. The fiscal year 2009 Peer Reviewed Cancer Research Program Collaborative Translational Science Award requests applications from these focus areas only: Research into melanoma and other skin cancers related to deployments of service members to areas of high exposure by: (A) Understanding molecular and immunological effects of ultraviolet at the level of the cell and at the level of the human host, and (B) the genetic epidemiology and increased susceptibility to melanoma and other skin cancers. Correlative clinical research studies are allowed under this mechanism. Clinical trials are not permitted under this mechanism. Funding: Each collaborative partner will be a principal investigator (PI), and a separate award will be made to each partner's institution. The PIs are expected to be equal partners in the research, and the direct cost of funding should be divided accordingly unless otherwise warranted and clearly justified. The maximum period of performance is 5 years. The maximum combined allowable funding for each collaborative partnership for the entire period of performance, regardless of whether there are two or three PIs, is $1,125,000, including direct and indirect costs. The maximum allowable funding is to be divided between the PIs of each collaborative partnership. The applicant may request the entire maximum direct cost amount for a project that may be less than the maximum 5-year period of performance. Regardless of the period of performance proposed, the applicant may not exceed the maximum direct cost. In addition to the direct costs, indirect costs may be proposed in accordance with the institution's negotiated rate agreement. Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DOD Peer Reviewed Cancer Genetic/Environmental New Investigator Awards http://www.grants.gov/
New Investigator Awards support the career transition and/or continued development of promising principal investigators (PIs) who have innovative, high-impact ideas or new technologies applicable to genetic cancer research and its relation to exposures to the various environments that are unique to a military lifestyle. No other topic areas will be allowed. The New Investigator Award supports independent PIs (detailed qualification outlined in the program announcement on pages 3 to 4) in the early stages of their careers, and it strongly encourages a designated collaborator. Funding: The maximum period of performance is 3 years. The maximum allowable direct cost amount for the entire period of performance is $275,000. In addition to direct costs, indirect costs may be proposed in accordance with the institution's negotiated rate agreement. Deadlines: Preapplication (preproposal) through http://cdmrp.org/ required and due: 5 August 2009, by 5:00 p.m. Eastern Daylight Time. Preproposals will be screened, and submission of full application is by invitation. Invitations from the Peer Reviewed Cancer Research Program to selected preapplicants: 19 October 2009. Application submitted through www.grants.gov due: 9 December 2009, by 11:59 p.m. Eastern Standard Time. Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DOD Peer Reviewed Cancer Pediatric Brain Tumor Synergistic Idea Awards
The Synergistic Idea Awards must address pediatric brain tumors within the field of childhood cancer. No other topic areas should be addressed in this funding opportunity. Within the field of pediatric brain-tumor studies, the study of rare pediatric brain tumors is especially encouraged. Studies should include comprehensive methods for tumor data collection and host data collection. The Synergistic Idea Award supports innovative approaches to pediatric brain-tumor research involving two to four independent, faculty-level (or equivalent) principal investigators (PIs). These investigators should use synergistic and complementary perspectives to address a central problem or question in pediatric brain tumor research. This award is designed to encourage and support both new and preexisting partnerships. The Synergistic Idea Award requires that investigators jointly design a single project. However, each partner will be recognized as a PI, must submit a separate application, and will receive an individual award. Clinical trials are not permitted under this mechanism. Submission of preliminary data relevant to pediatric brain tumors and the proposed project is not required. If preliminary data is provided, it should be from the laboratory of the initiating PI or partnering PI(s). Funding is available for up to a maximum period of performance of 3 years. The maximum combined allowable funding for one collaborative partnership for the entire period of performance, regardless of whether there are two, three, or four PIs, is $1,750,000, including direct and indirect costs. The maximum allowable funding is to be divided between the PIs of each collaborative partnership. Deadlines: Preapplication (preproposal) through http://cdmrp.org/ required and due: 5 August 2009, by 5:00 p.m. Eastern Daylight Time. Preproposals will be screened and submission of full application is by invitation. Invitations from the Peer Reviewed Cancer Research Program to selected preapplicants: 19 October 2009. Application submitted through www.grants.gov due: 9 December 2009, by 11:59 p.m. Eastern Standard Time. Deadline: 2009-08-05; 2009-12-09
- Department of Health and Human Services. National Institutes of Health
-
Partnerships for Biodefense Viral Pathogens (R01)
This funding opportunity announcement issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, invites research applications for projects that support the development of new therapeutics, immunotherapeutics, or medical diagnostics for NIAID Category A, B, or C viral pathogens. Deadline: 2009-08-24
- Department of Health and Human Services. National Institutes of Health
-
Partnerships for Biodefense Food- and Water-borne Diseases (R01)
This funding opportunity announcement issued by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, invites research applications for projects that support the development of therapeutics, immunotherapeutics, medical diagnostics, and broad-spectrum vaccines for NIAID Category B food- and water-borne priority pathogens and toxins. Deadline: 2009-08-24
- Department of Health and Human Services. National Institutes of Health
-
The Early Detection Research Network: Biomarker Developmental Laboratories (U01)
This funding opportunity announcement solicits cooperative agreement applications for Biomarker Developmental Laboratories (BDLs), one of the four components of the Early Detection Research Network. EDRN is a national consortium funded to discover, develop, and validate biomarkers for early cancer detection, risk assessment, and the molecular diagnosis and prognosis of early cancer. BDLs are responsible for the development and characterization of new, or the refinement of existing, biomarkers and biomarker assays. The other three main components of EDRN are: the Biomarker Reference Laboratories (BRLs), which serve as network resources for clinical and laboratory validation of biomarkers; Clinical Validation Centers, which conduct clinical research on the validation of biomarkers in early cancer detection and risk assessment and serve as resource centers for EDRN by participating in collaborative biomarker-validation studies and collaborating with EDRN BDLs and BRLs; and the Data Management and Coordinating Center, which supports statistical and computational analyses, informatics infrastructure, and the coordination of networkwide meetings and conferences. Deadline: 2009-09-29
- Department of Health and Human Services. National Institutes of Health
-
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01)
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) solicits applications for the Cancer Intervention and Surveillance Modeling Network (CISNET). The goal of CISNET is to use simulation and other modeling techniques (a) to understand the impact of cancer-control interventions (i.e., screening, treatment, prevention) on national trends in cancer rates, and (b) to inform national/regional/local decisions on the most efficient utilization of existing and emerging technologies and strategies for the control of cancer. This FOA expands CISNET efforts focused on four cancer sites (prostate, lung, colorectal, and breast) and will also cover two additional sites (cervical and esophageal cancer). Expansion into new areas of modeling (identified in the FOA) is also encouraged. This FOA will support collaborative, interactive projects involving groups of researchers that would put forward a program of comparative modeling, as well as to allow coverage across the important cancer-control issues and relevant specific focus areas for the selected organ site. Deadline: 2009-10-03
- Department of Health and Human Services. National Institutes of Health
-
Enterics Research Investigational Network Cooperative Research Centers (U19)
The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, invites applications from single institutions and consortia of institutions to participate in the funding opportunity announcement (FOA) Enterics Research Investigational Network (ERIN) Cooperative Research Centers (CRCs). The purpose of this FOA is to establish ERIN CRCs, a coordinated enterics research program designed to bridge the gaps between basic, translational, and clinical research on enteric disease agents, including toxins. The network is designed to be a multicenter effort with collaborative relationships between ERIN CRC investigators and NIAID program staff. Deadline: 2009-10-17
- National Science Foundation.
-
Science and Engineering Visualization Challenge
When the left brain collaborates with the right brain, science emerges with art to enhance communication and understanding of research results-illustrating concepts, depicting phenomena and drawing conclusions. The National Science Foundation (NSF) and the journal , published by the American Association for the Advancement of Science, invite you to participate in the 6th annual Science and Engineering Visualization Challenge. The competition recognizes scientists, engineers, visualization specialists, and artists for producing or commissioning innovative work in visual communication. Deadline: 2009-09-15
- Pew Charitable Trusts.
-
Pew Latin American Fellows Program
The goal of this program is to promote continued excellence in biomedical research and to develop research in Latin America by supporting outstanding, competitively selected biomedical scientists who will receive advanced training in the United States and return home to teach and undertake research. Deadline: 2009-10-01
- Positive Neuroscience Project.
-
Templeton Positive Neuroscience Awards
Supported by a grant from the John Templeton Foundation, the University of Pennsylvania Positive Psychology Center has established the Templeton Positive Neuroscience Awards to advance research at the intersection of neuroscience and positive psychology. Up to 20 2-year grants averaging $200,000 will be awarded to researchers worldwide who hold a Ph.D., M.D., or equivalent at the time of application and are no more than 10 years beyond their doctorate or postdoctoral education. Research topics of interest include but are not limited to neuroscientific explorations of: virtue, strength, and positive emotion; exceptional abilities; meaning and positive purpose; decisions, values, and free will; and religious belief, prayer, and meditation. To apply, interested applicants should submit a letter of intent and a curriculum vitae by 30 September 2009. The official announcement and application details for this opportunity can be found on the Positive Neuroscience Web site: www.posneuroscience.org. Deadline: 2009-09-30
- Social Science Research Council.
-
The Abe Fellowship is designed to encourage international, multidisciplinary research on topics of pressing global concern. The program seeks to foster the development of a new generation of researchers who are interested in policy-relevant topics of long-range importance and who are willing to become key members of a bilateral and global research network built around such topics. Applications are welcome from scholars and nonacademic research professionals. Funding for the program is provided by the Japan Foundation Center for Global Partnership. Deadline: 2009-09-01
- The ASCO Cancer Foundation.
-
Advanced Clinical Research Award in Sarcoma
The Advanced Clinical Research Award (ACRA) is designed to fund mid-career investigators who are committed to clinical cancer research and who wish to conduct original research not currently funded. For the 2010 ACRA in Sarcoma, preference will be given to proposals involving therapeutic vaccine or immunotherapeutic approaches for sarcoma. The grant is funded at the level of $450,000, paid in three annual increments of $150,000 per year on 1 January. The Advanced Clinical Research Award in Sarcoma is intended to support proposals with a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. The American Soceity of Clinical Oncology's (ASCO's) definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate; on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or the epidemiology of neoplastic disease" (, Vol. 14, No. 2, 1996, pp. 666-670). Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. The ASCO Cancer Foundation will accept applications from a single principal investigator or from two co-PIs. This option of a joint application is intended to promote interdisciplinary research and to help bring advances in immunotherapy to sarcoma patients. There will be no preference for either single or joint PI applications. Both will be equally considered and will be scored based on the merit of the application and the proposed research project. The 2010 ACRA in Sarcoma will be awarded to two joint PIs only if the two PIs both meet all of the eligibility criteria. Deadline: 2009-08-06
- The ASCO Cancer Foundation.
-
The Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The ASCO Cancer Foundation welcomes application submissions in all oncology subspecialties. The total award amount is $200,000 payable on 1 July in annual increments of $66,666 over 3 years. The number of CDA grants in each funding cycle is not predetermined by the ASCO Cancer Foundation. Awards are given based on individual merit and availability of funds. The Career Development Award is intended to support proposals with a clinical research focus. ASCO's definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate, on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or epidemiology of neoplastic disease" (, Vol. 14, No. 2, 1996, pp. 666-670). Proposals must have a patient-oriented focus including a clinical research study involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. The full request for proposals can be downloaded from the ASCO Cancer Foundation Web site. Deadline: 2009-09-09
- The ASCO Cancer Foundation.
-
Improving Cancer Care Grant, funded by Susan G. Komen for the Cure
Purpose: The ASCO Cancer Foundation Improving Cancer Care Grant, funded by Susan G. Komen for the Cure, will provide extramural research funding to address important issues regarding access to health care, quality of care, and delivery of care with general applicability to breast cancer. The goal of this program is to encourage multidisciplinary research that will have a major impact on breast-cancer care. This grant opportunity is part of the Susan G. Komen for the Cure/ASCO Cancer Foundation Research Initiative. Research Objectives: The Improving Cancer Care Grants will provide funding for research studies that implement and evaluate new ways to solve major problems in quality of, access to, and delivery of health care. Proposals must be focused on developing solutions to current problems, not just describing disparities in care that currently exist. Research teams that have previously laid the groundwork in these areas by describing existing problems are particularly encouraged to submit proposals to implement and study potential solutions. Project proposals are not required to focus on breast cancer, but the study findings must have general applicability to breast-cancer care. Funding Available: Susan G. Komen for the Cure and the ASCO Cancer Foundation expect to award up to three research grants, each totaling $1.35 million. This money will be distributed as $450,000 total costs per year over 3 years. Indirect costs will be limited to 25% of total costs. Deadline: 2009-09-01
- The ASCO Cancer Foundation.
-
The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. The ASCO Cancer Foundation welcomes application submissions in all oncology subspecialties. The total award amount is $50,000 for 1 year, payable on 1 July and 1 January in two equal installments. The number of YIA grants in each funding cycle is not predetermined by the ASCO Cancer Foundation. Awards are given based on individual merit and the availability of funds. The Young Investigator Award is intended to support proposals with a clinical research focus. ASCO's definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate, on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or epidemiology of neoplastic disease" (, Vol. 14, No. 2, 1996 pp. 666-670). In YIA proposals, preclinical in vitro and/or animal studies are acceptable as long as the outcome of these studies would ultimately lead to patient-oriented clinical research. The full request for proposals can be downloaded from the ASCO Cancer Foundation Web site. Deadline: 2009-09-09
[ top ]
GrantsNet Express
GrantsNet Express offers a new listing each week by e-mail of science funding opportunities from private foundations and organizations, as well as new U.S. government science grant announcements.
Deadline Watch
(Image: comstock)
- The Ben and Catherine Ivy Foundation.
-
Deadline: 2009-07-20
- National Science Foundation.
-
Faculty Early Career Development (CAREER) Program
Deadline: 2009-07-21
- American Heart Association.
-
AHA National Clinical Research Program
Deadline: 2009-07-22
- National Science Foundation.
-
Improvements to Biological Research Collections
Deadline: 2009-07-24
- Robert Wood Johnson Foundation.
-
Active Living Research: Investigating Policies and Environments to Support Active Communities
Deadline: 2009-07-26
- Department of Defense.
-
Remoted Analog-to-Digital Converter with De-serialization and Reconstruction (RADER)
Deadline: 2009-07-28
- Department of Health and Human Services. National Institutes of Health
-
NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)
Deadline: 2009-07-30
- CSL Behring.
-
U.S.-based Hemophilia Treatment Centers
Deadline: 2009-07-31
- Council for International Exchange of Scholars.
-
Fulbright Postdoctoral Research in Egypt
Deadline: 2009-08-01
- Council for International Exchange of Scholars.
-
Fulbright Postdoctoral Research in Israel
Deadline: 2009-08-01
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2009-08-03
- Society for Imaging Informatics in Medicine (SIIM).
-
Deadline: 2009-08-03
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2009-08-03
- Society for Imaging Informatics in Medicine (SIIM).
-
2010 Small Grant for Imaging Informatics Training
Deadline: 2009-08-03
- Society for Imaging Informatics in Medicine (SIIM).
-
2010 Small Grant for Product Support Development
Deadline: 2009-08-03
- National Science Foundation.
-
Deadline: 2009-08-03
- Society for Imaging Informatics in Medicine (SIIM).
-
Deadline: 2009-08-03
- National Science Foundation.
-
Partnerships in Astronomy and Astrophysics Research and Education
Deadline: 2009-08-03
- Society for Imaging Informatics in Medicine (SIIM).
-
Deadline: 2009-08-03
- Nancy R. Gelman Foundation.
-
Deadline: 2009-08-05
- National Science Foundation.
-
Basic Research to Enable Agricultural Development
Deadline: 2009-08-05
- Department of Health and Human Services. National Institutes of Health
-
Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44])
Deadline: 2009-08-05
- Environmental Protection Agency.
-
Deadline: 2009-08-05
- Department of Health and Human Services. National Institutes of Health
-
Advanced Tools and Technologies for Cerebrospinal Fluid Shunts STTR (R41/R42)
Deadline: 2009-08-05, 2009-12-05, 2010-04-05
- Department of Health and Human Services. National Institutes of Health
-
Advanced Tools and Technologies for Cerebrospinal Fluid Shunts SBIR (R43/R44)
Deadline: 2009-08-05, 2009-12-05, 2010-04-05
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2009-08-05; 2009-12-05
- Department of Defense.
-
DoD Peer Reviewed Cancer Pediatric Brain Tumor Synergistic Idea Awards
Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DoD Peer Reviewed Cancer Melanoma Collaborative Translational Science Awards
Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DoD Peer Reviewed Cancer Genetic/Environmental New Investigator Awards
Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DoD Peer Reviewed Cancer Mentor-Predoctoral Fellow Research Awards
Deadline: 2009-08-05; 2009-12-09
- Department of Defense.
-
DoD Peer Reviewed Cancer Genetic/Environmental Idea Awards
Deadline: 2009-08-05; 2009-12-09
- The ASCO Cancer Foundation.
-
Advanced Clinical Research Award in Sarcoma
Deadline: 2009-08-06
- National Science Foundation.
-
Sedimentary Geology and Paleobiology
Deadline: 2009-08-07; 2010-01-16; 2010-07-16
- National Science Foundation.
-
Major Research Instrumentation Program
Deadline: 2009-08-10
- American Association for Cancer Research.
-
AACR Judah Folkman Career Development Award for Anti-Angiogenesis Research
Deadline: 2009-08-10
- American Association for Cancer Research.
-
AACR-National Brain Tumor Society Fellowship
Deadline: 2009-08-10
- US Department of Defense - Office of Naval Research.
-
Sciences Addressing Asymmetric Explosive Threats
Deadline: 2009-08-13
- National Science Foundation.
-
Strategic Technologies for Cyberinfrastructure
Deadline: 2009-08-13
- Department of Defense.
-
DoD Psychological Health/ Traumatic Brain Advanced Technology-Therapeutic Development Awards
Deadline: 2009-08-14; 2009-10-28
- Department of Defense.
-
DoD Psychological Health/ Traumatic Brain Investigator-Initiated Research Awards
Deadline: 2009-08-14; 2009-10-28
- Department of Health and Human Services. National Institutes of Health
-
NHLBI Systems Biology Collaborations (R01)
Deadline: 2009-08-14; 2009-12-14; 2010-08-14; 2010-12-14
- National Science Foundation.
-
Deadline: 2009-08-15
- National Science Foundation.
-
Decision, Risk and Management Sciences
Deadline: 2009-08-15
- National Science Foundation.
-
Deadline: 2009-08-15
- National Science Foundation.
-
Deadline: 2009-08-15
- Mesothelioma Applied Research (Meso) Foundation, Inc..
-
Deadline: 2009-08-15
- National Science Foundation.
-
Deadline: 2009-08-15
- National Science Foundation.
-
Geography and Regional Science
Deadline: 2009-08-15
- National Science Foundation.
-
Deadline: 2009-08-15
- National Science Foundation.
-
Deadline: 2009-08-15
- National Science Foundation.
-
Ocean Technology and Interdisciplinary Coordination
Deadline: 2009-08-15
- National Science Foundation.
-
Deadline: 2009-08-15, 2009-10-15, 2010-01-15, 2010-02-15
GrantsNet Sponsorship
Sponsorship opportunities are now available on GrantsNet and GrantsNet Express. Please contact Daryl Anderson for more information.
[ top ]
10.1126/science.caredit.f20090717 |
